Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8030287

DNA vaccine against North American spring viremia of carp virus

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 pr

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8025887

Avirulent, immunogenic flavivirus chimeras

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022190

Immuno-molecules containing viral proteins, compositions thereof and methods of using

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022175

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012490

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003685

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999001

Antiviral compounds and methods of using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994143

Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nu

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994139

Antiviral therapeutic agents

BioCryst Pharmaceuticals, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7985769

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7976868

Liposomes comprising duramycin and anti-viral agents

The Board of Regents of the University of Texas System · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7973020

Compositions and methods for inhibiting expression of a gene from the ebola virus

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968298

Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhi

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964187

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964186

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964559

MVL, an antiviral protein from a cyanobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951383

Attenuated parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951770

Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated

Northwestern University · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943148

Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccin

The United States of America as represented by the Secretary of the Army · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7932074

Multivalent human-bovine rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928080

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted